Hamlet BioPharma will be presenting at Aktiedagen, Aktiespararna, on Monday, October 9th, in Lund at 12:10 CET

Hamlet Biopharma
|
October 5, 2023

Hamlet BioPharma is inviting you to join a presentation at Aktiedagen, Aktiespararna, on Monday October 9th at 12.10 CET, Elite Hotel Ideon, Lund. The company´s strong and innovative projects portfolio will be presented as well as the clinical trials of our cancer and infection therapies. We will also introduce our new CEO, Petter Segelman Lindqvist.

We welcome shareholders, investors and interested parties to join.

The presentation will be held in Swedish with the presentation slides in English and is free of charge if you are pre-registered at aktiespararna.se.

 

Use this link for more information and to join the presentation:

https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-9-oktober-39146

For further information, please contact:

 

Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49

catharina.svanborg@hamletpharma.com

Petter Segelman Lindqvist, CEO Hamlet BioPharma

petter.s.lindqvist@hamletbiopharma.com

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.